NEW YORK (GenomeWeb News) – Contract research organization AI Biotech announced it has received a 30-month, $4.3 million contract to carry out a next-generation sequencing project.

The work being carried out is classified and company President and CSO Robert Harris declined to provide specifics about the project to GenomeWeb Daily News, saying only that it is broad-based and will involve the sequencing of "many individual human genomes." The goal is to develop genomic information and methods of handling and processing the data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.